Toxoplasma gondii: Lifecycle, Neurological Infection, and Host Manipulation

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan protozoan parasite with a heteroxenous lifecycle that encompasses both definitive hosts (felids) and a broad range of intermediate hosts, including mammals and birds [1, 2]. The parasite is recognized for its capacity to establish chronic infection within neural tissues and for its remarkable ability to alter the behavior of infected intermediate hosts, particularly rodents, in a manner that increases the probability of predation by felids [2]. This article provides an exhaustive review of the T. gondii lifecycle, the molecular mechanisms governing neurological infection and blood-brain barrier traversal, and the neuroimmunological basis of host manipulation. The discussion is framed within the context of veterinary medicine, diagnostics, and comparative biology, emphasizing data from felid, rodent, and livestock models.

Definitive and Intermediate Host Lifecycle

The lifecycle of T. gondii is divided into sexual reproduction, which occurs exclusively within the intestinal epithelium of felids (definitive hosts), and asexual reproduction, which occurs in a wide array of warm-blooded intermediate hosts [2]. Understanding the complete lifecycle is critical for veterinary diagnostics and for designing intervention strategies.

Sexual Cycle in Felids

Following ingestion of tissue cysts (containing bradyzoites) by a susceptible felid, the cyst wall is dissolved by gastric and intestinal proteases. Bradyzoites are released and penetrate the epithelial cells of the small intestine, where they undergo multiple rounds of asexual proliferation (schizogony) before differentiating into gametocytes. Fertilization yields unsporulated oocysts that are shed in the feces. Sporulation occurs in the external environment within 1 to 5 days, producing sporulated oocysts containing two sporocysts, each with four sporozoites [2].

A key determinant of host range for the sexual cycle is the availability of linoleic acid and the activity of intestinal delta-6-desaturase. Felids possess a unique defect in this enzyme, resulting in the accumulation of linoleic acid in the intestinal mucosa, which is essential for the parasite's sexual development. Non-felid species lacking this biochemical environment do not support oocyst shedding [3].

Asexual Cycle in Intermediate Hosts

Intermediate hosts, including rodents, birds, livestock (sheep, goats, pigs), and wildlife (e.g., Eurasian beavers, Castor fiber), become infected through ingestion of sporulated oocysts from contaminated feed or water, or through ingestion of tissue cysts in raw or undercooked meat [4, 1]. Following ingestion, sporozoites (from oocysts) or bradyzoites (from tissue cysts) invade intestinal epithelial cells and differentiate into the rapidly replicating tachyzoite stage. Tachyzoites disseminate via the bloodstream and lymphatics to reach a variety of tissues, with a notable tropism for neural and muscle tissues.

Under pressure from the host immune response, tachyzoites differentiate into slowly replicating bradyzoites, which form intracellular tissue cysts primarily within the brain, skeletal muscle, and myocardium. These cysts persist for the lifetime of the host and serve as a reservoir for transmission to definitive hosts.

The developmental plasticity of the bradyzoite stage has been demonstrated using ex vivo models, which show that bradyzoites can recrudesce into tachyzoites upon immunosuppression or other stressors [5]. Transcriptomic analyses have revealed stage-specific regulatory programs and metabolic adaptations that drive oocyst sporulation and bradyzoite differentiation [6, 7]. For instance, cap-independent translation directs stress-induced differentiation, allowing the parasite to rapidly switch from fast-growing tachyzoites to dormant bradyzoites under adverse conditions [8]. Additionally, the serine/threonine phosphatase PTPA governs stress-responsive differentiation and metabolic homeostasis in T. gondii [9].

Lifecycle Diagram

graph TD
    A[Felid definitive host], >|Ingestion of tissue cysts| B[Bradyzoite release in intestine]
    B, > C[Sexual cycle: schizogony and gametogony]
    C, > D[Unsporulated oocysts shed in feces]
    D, >|Sporulation in environment| E[Sporulated oocysts]
    E, >|Ingestion by intermediate host| F[Sporozoite excystation]
    F, > G[Conversion to tachyzoites]
    G, >|Dissemination| H[Acute infection: tachyzoites in multiple tissues]
    H, >|Immune pressure| I[Conversion to bradyzoites and cyst formation]
    I, > J[Chronic infection: brain, muscle]
    J, >|Predation by felid| A
    I, >|Immunosuppression| G
    J, >|Ingestion by carnivore/omnivore| K[New intermediate host]
    K, > L[Same asexual cycle]
    L, > M[Chronic infection with tissue cysts]
    M, > A

Molecular Regulation of Stage Conversion

The transition between tachyzoites and bradyzoites is governed by complex regulatory networks involving transcription factors, RNA-binding proteins, and stress-response pathways. The Spt5-like transcription elongation factor has been characterized in T. gondii, suggesting that transcriptional elongation is a point of regulation during stage conversion [10]. The genome-wide transcriptomic analysis by Magoye et al. identified stage-specific metabolic adaptations, including upregulation of enzymes for glycolysis and amylopectin synthesis in sporulating oocysts, as well as distinct splicing patterns during bradyzoite development [6]. Proteomic comparisons between developmental stages further support the existence of stage-specific protein expression profiles [11].

Iron and zinc homeostasis is critical for parasite growth. The ZFT transporter has been identified as the major iron and zinc transporter in T. gondii, and its function is essential for tachyzoite proliferation [12].

Mechanisms of Crossing the Blood-Brain Barrier

Neurotropism is a hallmark of T. gondii infection. The parasite must traverse the blood-brain barrier (BBB) to establish chronic infection within the central nervous system (CNS). While the precise mechanisms remain incompletely understood, several models have been proposed based on in vitro and in vivo studies.

Paracellular and Transcellular Migration

T. gondii tachyzoites are capable of crossing the BBB by at least two routes. First, paracellular migration involves the disruption of tight junctional complexes between brain microvascular endothelial cells, allowing the parasite to pass between cells without directly infecting them. This process is thought to be facilitated by secreted proteases and by the mechanical forces generated during gliding motility. The lifecycle of an actin filament in T. gondii gliding involves nucleation, elongation, and capping, providing the necessary force for cellular penetration and migration [13]. Second, transcellular migration occurs when tachyzoites actively invade and replicate within brain microvascular endothelial cells, eventually lysing the host cell and releasing progeny into the brain parenchyma.

The "Trojan Horse" Mechanism

An alternative and well-supported model is the "Trojan horse" mechanism, in which infected leukocytes (particularly monocytes and dendritic cells) carrying intracellular tachyzoites migrate across the BBB, transporting the parasite into the CNS without direct endothelial invasion. The parasite is known to manipulate host cell signaling to enhance the migratory capacity of infected leukocytes. Hyper-motility and increased adhesion molecule expression have been observed in T. gondii -infected monocytes in vitro, facilitating their traversal of endothelial monolayers.

Key Molecular Mediators of Invasion

The invasion of host cells by T. gondii is a multistep process involving parasite actin-myosin motor-driven gliding, secretion of adhesins from micronemes and rhoptries, and formation of a moving junction. Several molecular players have been identified. Myristoylation of parasite proteins is critical for host cell penetration, as shown by profiling of N-myristoylated proteins that are essential for invasion [14]. A novel protein complex required for effector translocation across the parasitophorous vacuole membrane (PVM) has been identified, indicating that the PVM is a dynamic interface for host-parasite interactions [15]. The autophagy-related protein ATG5 has also been shown to play a role in T. gondii replication and egress from host cells, suggesting a link between host cell autophagy machinery and parasite lifecycle progression [16]. Calcium-calmodulin-dependent protein kinases (e.g., TgCDPKs) regulate key events such as microneme secretion, gliding motility, and egress [17]. The process of egress itself is a regulated event involving calcium signaling, protease activation, and permeabilization of the PVM and host cell membrane [18].

Host Manipulation: Rodent Behavioral Alteration

One of the most extensively documented and studied phenomena in parasitology is the ability of T. gondii to alter the behavior of infected intermediate hosts, specifically rodents, to increase the likelihood of predation by felids.

Loss of Innate Fear of Feline Odors

Rodents infected with T. gondii exhibit a characteristic and highly specific behavioral phenotype: they lose their innate aversion to the odor of feline predators (e.g., cat urine) and, in some cases, even show a paradoxical attraction to these odors. This change is not due to a general loss of olfaction or cognitive function, as infected rodents retain normal responses to other predator odors (e.g., fox or weasel). This behavioral manipulation is interpreted as a parasitic adaptation to complete the lifecycle by facilitating transmission from the intermediate host to the definitive host.

Neurobiological and Molecular Mechanisms

The mechanisms underlying this behavioral manipulation are multifaceted and involve alterations in neurotransmitter signaling, gene expression, and immune responses within the brain. Infection with T. gondii leads to the formation of cysts in multiple brain regions, including the amygdala, the prefrontal cortex, and the hypothalamus. While cysts are distributed throughout the brain, they display a non-random distribution, with a predilection for certain areas. It has been shown that the parasite does not destroy the infected neurons but rather modulates their function.

Key mechanistic findings include:

• Dopamine metabolism: T. gondii encodes two aromatic amino acid hydroxylases (AAH1 and AAH2) that can produce L-DOPA, a precursor to dopamine. Increased dopamine levels have been observed in the brains of infected rodents, particularly in regions involved in fear processing and reward, such as the amygdala and nucleus accumbens. Elevated dopamine in the amygdala is thought to blunt the fear response to feline cues.
• Testosterone modulation: In male rodents, chronic infection is associated with elevated testosterone levels, which can increase risk-taking behavior and reduce anxiety.
• Glial cell activation and neuroinflammation: Infection induces a robust microglial and astrocytic response. The resulting local neuroinflammation, particularly in the amygdala, may disrupt normal synaptic signaling and fear processing.
• Direct neural activation: The parasite may directly modulate gene expression in infected neurons. For example, T. gondii infection has been shown to alter the expression of genes involved in neurotransmitter synthesis, receptor function, and synaptic plasticity, thereby rewiring neural circuits.

Evolutionary and Ecological Context

From an evolutionary perspective, the host manipulation strategy is highly successful. The loss of fear response increases the predation rate of infected rodents by felids, which provides a selective advantage for the parasite by ensuring its transmission. This strategy has been observed in both natural and laboratory settings. The ecological niche of T. gondii is closely tied to the distribution of felids. Studies that infer the ecological niche of T. gondii and Bartonella spp. in wild felids highlight the importance of felid density and environmental contamination in driving the parasite's epidemiology [19].

Diagnostic and Veterinary Perspectives

Detection of T. gondii infection in veterinary settings relies on a combination of serological, molecular, and histopathological methods.

Serological Assays

Commercially available enzyme-linked immunosorbent assays (ELISAs) are widely used for the detection of anti-T. gondii IgG and IgM antibodies in serum from cats, dogs, sheep, goats, and other species. The detection of IgM indicates recent infection, while IgG indicates chronic or past exposure. Serological surveys, such as the study on toxoplasmosis seroepidemiology in rural and urban communities in Chile, demonstrate the utility of these assays for population-level surveillance in both domestic and wild animals [20]. For detection in feline populations, serology is often combined with fecal oocyst examination.

Molecular Diagnostics

PCR-based assays targeting the 529 bp repetitive element, the B1 gene, or the ITS1 region of the rRNA gene offer high sensitivity and specificity for the detection of T. gondii DNA in tissues, biological fluids, and meat products. Molecular detection is particularly useful for diagnosing congenital toxoplasmosis, reactivated infections, and for screening meat for human consumption. For example, real-time PCR was used to detect T. gondii and non-zoonotic Sarcocystis species in commercial beef products [21]. In wildlife, molecular detection of T. gondii in free-living Eurasian beavers has been reported, highlighting the wide host range and the utility of PCR for surveillance in non-traditional hosts [4].

Comparative Veterinary Considerations

The diagnosis of toxoplasmosis in livestock is important for both animal health and food safety. In sheep and goats, infection can cause abortion, stillbirth, and neonatal losses. The parasite can be detected in aborted fetal tissues using PCR or histology. In cats, the diagnostic approach often involves serology (point-of-care tests and laboratory-based ELISAs) combined with fecal examination for oocysts, as detailed in the article on toxoplasmosis in cats.

Therapeutic and Prevention Strategies

No currently approved veterinary treatment can eliminate tissue cysts from an infected host. Antiprotozoal drugs such as clindamycin, sulfadiazine, and pyrimethamine are used for clinical toxoplasmosis, but they are mainly effective against tachyzoites. Prevention strategies focus on reducing oocyst exposure by preventing cats from hunting, maintaining indoor confinement, and avoiding the feeding of raw meat. In pigs and sheep, management practices to reduce environmental contamination with oocysts are critical. Vaccine development has been explored using recombinant antigens (e.g., rSAG1, rGRA2) and adenovirus-based vectors, but no licensed vaccine for veterinary use is widely available [22, 23, 24].

References

[1] Farhab M, Aziz MW, Shaukat A, et al. Review of Toxoplasmosis: What We Still Need to Do. Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872723/

[2] Attias M, Teixeira DE, Benchimol M, et al. The life-cycle of Toxoplasma gondii reviewed using animations. Parasit Vectors. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33228743/

[3] Martorelli Di Genova B, Wilson SK, Dubey JP, et al. Intestinal delta-6-desaturase activity determines host range for Toxoplasma sexual reproduction. PLoS Biol. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31430281/

[4] Jacquart A, Blake DP, Spiro S, et al. Occurrence and characterisation of Toxoplasma gondii infection in free-living Eurasian beavers, Castor fiber, from southern England. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41290903/

[5] Vizcarra EA, Goerner AL, Ulu A, et al. An ex vivo model of Toxoplasma recrudescence reveals developmental plasticity of the bradyzoite stage. mBio. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37675999/

[6] Magoye E, Schmid MW, Ramakrishnan C, et al. Genome-wide transcriptomic analysis of Toxoplasma gondii reveals stage-specific regulatory programs and metabolic adaptations driving oocyst sporulation. BMC Genomics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41761089/

[7] Chen LF, Han XL, Li FX, et al. Comparative studies of Toxoplasma gondii transcriptomes: insights into stage conversion based on gene expression profiling and alternative splicing. Parasit Vectors. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29996885/

[8] Dey V, Holmes MJ, Bastos MS, et al. Cap-independent translation directs stress-induced differentiation of the protozoan parasite Toxoplasma gondii. J Biol Chem. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39542243/

[9] Ying Z, Wu Y, Pei Y, et al. PTPA Governs Stress-Responsive Differentiation and Metabolic Homeostasis in Toxoplasma gondii. Cells. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40498010/

[10] Mitra P, Deshmukh AS, Gurupwar R, et al. Characterization of Toxoplasma gondii Spt5 like transcription elongation factor. Biochim Biophys Acta Gene Regul Mech. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30707945/

[11] Wang ZX, Zhou CX, Elsheikha HM, et al. Proteomic Differences between Developmental Stages of Toxoplasma gondii Revealed by iTRAQ-Based Quantitative Proteomics. Front Microbiol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28626452/

[12] Aghabi D, Gallego Rubio C, Cortijo Martinez M, et al. ZFT is the major iron and zinc transporter in Toxoplasma gondii. Elife. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41642226/

[13] Farhab M, Yuan YG. From nucleation to capping: The lifecycle of an actin filament in Toxoplasma gondii gliding. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41455416/

[14] Broncel M, Dominicus C, Vigetti L, et al. Profiling of myristoylation in Toxoplasma gondii reveals an N-myristoylated protein important for host cell penetration. Elife. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32618271/

[15] Marino ND, Panas MW, Franco M, et al. Identification of a novel protein complex essential for effector translocation across the parasitophorous vacuole membrane of Toxoplasma gondii. PLoS Pathog. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29357375/

[16] Wu F, Wu S, Ding Q, et al. ATG5 Plays a Role in Toxoplasma gondii Replication and Egress Within Host Cells. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253334/

[17] Kato K, Sugi T, Takemae H, et al. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog. Parasit Vectors. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27444499/

[18] Caldas LA, de Souza W. A Window to Toxoplasma gondii Egress. Pathogens. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30110938/

[19] Escobar LE, Carver S, Romero-Alvarez D, et al. Inferring the Ecological Niche of Toxoplasma gondii and Bartonella spp. in Wild Felids. Front Vet Sci. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29090215/

[20] Munoz-Zanzi C, Campbell C, Berg S. Seroepidemiology of toxoplasmosis in rural and urban communities from Los Rios Region, Chile. Infect Ecol Epidemiol. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26968154/

[21] Cancino-Faure B, Piñeiro-González A, D'Afonseca V, et al. Molecular detection of Toxoplasma gondii and non-zoonotic Sarcocystis species in commercial beef products from Chile. Acta Trop. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41812740/

[22] El Bissati K, Zhou Y, Paulillo SM, et al. Protein nanovaccine confers robust immunity against Toxoplasma. NPJ Vaccines. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29263879/

[23] Wang T, Yin H, Li Y, et al. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes. Parasite. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28367800/

[24] Allahyari M, Mohabati R, Amiri S, et al. Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii. Exp Parasitol. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27663469/

[25] Cataldo KM, Davis NM, Knoll LJ. Kinase inhibitors in organoid media influence Toxoplasma gondii growth and development. Microbiol Spectr. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41930945/

[26] Deng M, Gao F, Liu T, et al. T. gondii excretory proteins promote the osteogenic differentiation of human bone mesenchymal stem cells via the BMP/Smad signaling pathway. J Orthop Surg Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38951811/

[27] Ávila AR, Cabezas-Cruz A, Gissot M. mRNA export in the apicomplexan parasite Toxoplasma gondii: emerging divergent components of a crucial pathway. Parasit Vectors. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29370868/

[28] Fellows JD, Cipriano MJ, Agrawal S, et al. A Plastid Protein That Evolved from Ubiquitin and Is Required for Apicoplast Protein Import in Toxoplasma gondii. mBio. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28655825/